Key result
Serum digoxin levels show greater overlap between toxic and non-toxic ranges in elderly patients.
Why the study?
The precision and clinical value of serum digoxin estimation in elderly patients with multiple pathological and biochemical abnormalities were uncertain.
Does serum digoxin estimation accurately determine the state of digitalisation and toxicity in elderly patients?
Observational
Does serum digoxin estimation accurately determine the state of digitalisation and toxicity in elderly patients?
Serum digoxin estimation is valuable in elderly patients, but interpretation requires caution due to a greater overlap between toxic and non-toxic ranges compared to younger patients.
Answers are grounded in this paper and cite their sources.
Assay precision for digoxin is limited at lower levels amid elderly comorbidities; leaves open reliable monitoring in this population.
Using a standardized assay technique, serum digoxin has been estimated in a number of elderly patients. The precision possible with this technique is acceptable with higher, potentially toxic serumdigoxin levels but less so at lower levels. Standard conditions were virtually impossible to obtain in view of the many pathological and biochemical abnormalities so often present in the elderly A series of simple measurements was made to determine: the variation of serum digoxin between individuals receiving the same dose of oral digoxin, and in the same individuals at different times and the toxic and non-toxic ranges of serum digoxin. The overlap between toxic and non-toxic ranges was found to be considerably greater than previously reported in younger patients. A simple formula is suggested for the determination of the overall state of digitalisation in a given patient. It is concluded that for elderly patients in clinical situations, the estimation of serum digoxin is of definite value, but less certainly so than for younger subjects.
No takes yet. Share an insight, caveat, or question.
ROE et al. (1974) conducted an observational in Elderly patients receiving oral digoxin. Serum digoxin levels vs. Younger patients (historical) was evaluated on Variation of serum digoxin and toxic/non-toxic ranges. Serum digoxin estimation in elderly patients revealed a considerably greater overlap between toxic and non-toxic ranges than in younger patients, though it remains clinically valuable.
Synapse has enriched 10 related papers. Consider them for comparative context: